{"id":3230,"count":51,"description":"The MedsBase Diabetes parent catalogue groups all diabetes-related medications across the major drug classes. The detailed clinical breakdown by molecule family with full brand listing is in our \u03a6\u03ac\u03c1\u03bc\u03b1\u03ba\u03b1 \u03b3\u03b9\u03b1 \u0394\u03b9\u03b1\u03b2\u03ae\u03c4\u03b7<\/a> sub-category \u2014 please browse there for selection guidance and dosing context. All products are supplied by WHO-GMP \u03c0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03bf\u03c5\u03c2 \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ad\u03c2<\/strong>.\n\nDrug-class summary.<\/strong> Biguanides (metformin \u2014 first-line, Glycomet SR, Metford), sulfonylureas (gliclazide, glimepiride, glibenclamide, glipizide), DPP-4 inhibitors (sitagliptin Januvia, vildagliptin Galvus, saxagliptin Onglyza, linagliptin Trajenta, teneligliptin Ziten), SGLT-2 inhibitors (dapagliflozin Forxiga, empagliflozin Jardiance, canagliflozin Invokana \u2014 with cardio-renal protection benefits), pioglitazone (Pioz), meglitinides (repaglinide Novonorm, nateglinide Glinate), alpha-glucosidase inhibitors (acarbose Glucobay, voglibose Voglibite, miglitol Mignar), and rapid-acting insulin pens (insulin aspart Novorapid Flexpen, insulin glulisine Apidra SoloStar). Combination therapies pairing metformin with sulfonylurea, DPP-4 inhibitor, or SGLT-2 inhibitor reduce pill burden in poly-pharmacy patients.\n\nSpecialty agents.<\/strong> Lipaglyn (saroglitazar \u2014 dual PPAR \u03b1\/\u03b3 agonist for diabetic dyslipidaemia and NASH) as Lipaglyn<\/a>. Methycobalamin \/ cyanocobalamin injections for diabetic neuropathy as \u0395\u03b3\u03c7\u03cd\u03c3\u03b7 Methycobal<\/a>.\n\nWhat is NOT here.<\/strong> GLP-1 receptor agonists (semaglutide Ozempic, liraglutide Victoza, dulaglutide, tirzepatide) are stocked separately as part of our weight-management ordering \u2014 see \u039a\u03b1\u03bb\u03cd\u03c4\u03b5\u03c1\u03b5\u03c2 \u0395\u03bd\u03b1\u03bb\u03bb\u03b1\u03ba\u03c4\u03b9\u03ba\u03ad\u03c2 \u03c4\u03bf\u03c5 Ozempic 2026<\/a>. Long-acting basal insulins (insulin glargine, degludec, detemir) are listed in dedicated insulin sub-categories where in stock.\n\nDisambiguation.<\/strong> Desmopressin (Minirin tablet, Minirin Nasal Spray) is currently mis-listed in our diabetes catalogue. Desmopressin treats diabetes insipidus<\/strong> (a kidney disorder of water handling) and bedwetting \/ nocturia \u2014 NOT diabetes mellitus<\/strong> (the common type 1 \/ type 2 diabetes). Pages explicitly clarify this. Please move to the bladder-prostate \/ urology category once a dedicated bedwetting category exists.\n\n\u03a0\u03ce\u03c2 \u03bd\u03b1 \u03b5\u03c0\u03b9\u03bb\u03ad\u03be\u03b5\u03c4\u03b5.<\/strong> Type 2 diabetes new diagnosis \u2192 metformin first-line (titrate to 1.5\u20132 g\/day in divided doses). Inadequate control on metformin \u2192 add SGLT-2 inhibitor (cardio-renal benefit) or DPP-4 inhibitor (weight-neutral) or sulfonylurea (cheapest, hypoglycaemia risk). Established cardiovascular disease or heart failure \u2192 SGLT-2 inhibitor preferred regardless of HbA1c. Significant weight excess \u2192 SGLT-2 or GLP-1 RA. Hypoglycaemia risk (elderly, frail, lone) \u2192 avoid sulfonylureas, prefer DPP-4 inhibitors or SGLT-2. Type 1 diabetes \u2192 basal-bolus insulin regimen (specialist-initiated, not catalogued here).\n\n\u03a3\u03b7\u03bc\u03b1\u03bd\u03c4\u03b9\u03ba\u03cc.<\/strong> Sudden hyperglycaemia with nausea, vomiting, abdominal pain \u2192 check for diabetic ketoacidosis (especially type 1 or SGLT-2 inhibitor user), urgent assessment. Severe hypoglycaemia with reduced consciousness \u2192 glucose \/ glucagon, 999. New diagnosis or significant control change requires HbA1c monitoring at 3 months. Lifestyle (diet, weight, activity, smoking cessation, BP and lipid control) remains the foundation of all diabetes care.\n\nAll MedsBase Diabetes products ship from WHO-GMP \u03c0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03bf\u03c5\u03c2 \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ad\u03c2<\/strong> \u03bc\u03b5 \u03b4\u03b9\u03b1\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ae \u03c3\u03c5\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03af\u03b1 \u03ba\u03b1\u03b9 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03b3\u03b3\u03cd\u03b7\u03c3\u03b7\u03c2 \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2<\/a>.\n\n2026 buyer's guide:<\/strong> \u0394\u03b5\u03af\u03c4\u03b5 \u03c4\u03b7\u03bd shortlist \u03bc\u03b1\u03c2 Best Diabetes Medications 2026: 10 Top Picks Compared<\/a> \u03b3\u03b9\u03b1 \u03ba\u03b1\u03c4\u03b1\u03c4\u03ac\u03be\u03b5\u03b9\u03c2, \u03c0\u03af\u03bd\u03b1\u03ba\u03b1 \u03c3\u03c5\u03b3\u03ba\u03c1\u03af\u03c3\u03b5\u03c9\u03bd, \u03c3\u03b7\u03bc\u03b5\u03b9\u03ce\u03c3\u03b5\u03b9\u03c2 \u03b4\u03bf\u03c3\u03bf\u03bb\u03bf\u03b3\u03af\u03b1\u03c2 \u03ba\u03b1\u03b9 \u03c3\u03c5\u03bc\u03b2\u03bf\u03c5\u03bb\u03ad\u03c2 \u03b5\u03c0\u03b9\u03bb\u03bf\u03b3\u03ae\u03c2.","link":"https:\/\/medsbase.com\/el\/diabetes\/","name":"\u0394\u03b9\u03b1\u03b2\u03ae\u03c4\u03b7\u03c2","slug":"diabetes","taxonomy":"product_cat","parent":3223,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_cat\/3230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_cat\/3223"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product?product_cat=3230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}